New drug may slow rapid progression of Parkinson's disease

[Health - Medical Xpress - latest medical and]

Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a large phase 2 clinical trial published in Nature Medicine.

Continue reading...